SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

Correspondence 0001193125-25-334252 from FibroBiologics, Inc. (FBLG)

FibroBiologics, Inc.
Date: Dec. 29, 2025 · CIK: 0001958777 · Accession: 0001193125-25-334252

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-292407

Date
December 29, 2025
Author
Ruben A. Garcia
Form
CORRESP
Company
FibroBiologics, Inc.

Letter

Attention: Tyler Howes Registration Statement on Form S-1 File No. 333- 292407

RE: FibroBiologics, Inc. (the “Company”)

Dear Mr. Howes: Pursuant to Rule 461(a) under the Securities Act of 1933, as amended, the Company hereby respectfully requests that the effective date of the Company’s Registration Statement on Form S-1 (File No. 333-292407) be accelerated by the Securities and Exchange Commission to 3:00 p.m. Washington D.C. time on December 30, 2025, or as soon as practicable thereafter, unless the Company notifies you otherwise prior to such time. We request that we be notified of such effectiveness by a telephone call to me at 713.344.1482 and that such effectiveness also be confirmed in writing.

Very truly yours,
FibroBiologics, Inc.

Show Raw Text
CORRESP
 1
 filename1.htm

 CORRESP

 FIBROBIOLOGICS, INC. 455 E. Medical Center Blvd. Suite 300 Houston, Texas 77598 December 29, 2025 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance Office of Life Sciences 100 F Street, N.E. Washington, D.C. 20549

 Attention:
 Tyler Howes

 RE:
 FibroBiologics, Inc. (the “Company”)

 Registration Statement on Form S-1

 File No. 333- 292407

 Dear Mr. Howes: Pursuant to Rule 461(a) under the Securities Act of 1933, as amended, the Company hereby respectfully requests that the effective date of the Company’s Registration Statement on Form S-1 (File No. 333-292407) be accelerated by the Securities and Exchange Commission to 3:00 p.m. Washington D.C. time on December 30, 2025, or as soon as practicable thereafter, unless the Company notifies you otherwise prior to such time. We request that we be notified of such effectiveness by a telephone call to me at 713.344.1482 and that such effectiveness also be confirmed in writing.

 Very truly yours,

 FibroBiologics, Inc.

 By:
 /s/ Ruben A. Garcia

 Name:
 Ruben A. Garcia

 Title:
 General Counsel